Navigation Links
Janssen Pharmaceutical Companies of Johnson & Johnson Submit Citizen Petition to the U.S. FDA Regarding Naming of Biosimilars
Date:1/8/2014

WASHINGTON, Jan. 8, 2014 /PRNewswire-USNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) today submitted a Citizen Petition to the U.S. Food and Drug Administration (FDA) asking the agency to require biosimilars to bear nonproprietary names that are similar to, but not the same as, those of their reference products or of other biosimilars. The Petition states that distinguishable names are essential for enhancing patient safety and to ensure effective pharmacovigilance. 

"Ensuring biosimilars bear distinguishable names is of critical importance for patient safety," said Jay P. Siegel, M.D., Chief Biotechnology Officer and Head, Scientific Strategy and Policy, Johnson & Johnson.  "Names that are similar but not the same will appropriately reflect the legal and scientific reality that biosimilars are similar to but not the same as their reference products or other biosimilars."   

As FDA continues to implement the Biologics Price Competition and Innovation Act, the question of how biosimilars will be named must be addressed.  This question is currently being evaluated and will be addressed by the World Health Organization (WHO) and health authorities around the world.  Janssen submitted its Citizen Petition to communicate the company's position that requiring distinguishable names for biosimilars is critical for the safety of patients globally.

According to the Janssen Citizen Petition, the naming of biosimilars could have important patient safety implications beyond the name itself, including pharmacovigilance, product switching and extrapolation of indications.  Patients, their physicians and regulatory authorities such as the FDA need to know precisely which biological product has been used to
'/>"/>

SOURCE The Janssen Pharmaceutical Companies of Johnson & Johnson
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Janssen Research & Development Submits XARELTO® (rivaroxaban) to U.S. FDA for the Treatment and Prevention of Recurrent Venous Thromboembolism
2. Janssen Research & Development Submits New Drug Application to U.S. FDA for Canagliflozin to Treat Patients with Type 2 Diabetes
3. Janssen Announces Initiation Of Phase 3 Development Program For Sirukumab In Rheumatoid Arthritis
4. Janssen Biotech Announces Global License and Development Agreement for Investigational Anti-Cancer Agent Daratumumab
5. West Announces Agreement with Janssen Biotech to Develop and Commercialize a New Self-injection Technology
6. Janssen Announces Collaboration with Vertex on Phase 2 Study to Investigate an All-Oral Regimen of Simeprevir (TMC435) and VX-135 for Treatment of Hepatitis C
7. Janssen and Johnson & Johnson to Provide Webcast Presentation of Immunology Pivotal Phase 3 Data Being Presented at the American College of Rheumatology Annual Meeting
8. Efficacy and Safety Data from Phase 2B Trials of Janssens Simeprevir in Hepatitis C Patients with Advanced Fibrosis of the Liver Presented at Annual Meeting of the American Association for the Study of Liver Diseases
9. Janssen Research & Development Announces Establishment of Global Cross-Pharmaceutical Clinical Trial Investigator Databank
10. Janssen Research & Development Submits New Drug Application to U.S. FDA for Canagliflozin/Metformin Fixed-Dose Combination Therapy to Treat Patients with Type 2 Diabetes
11. Janssen Labs at San Diego Expands to Add Concept Lab and Open Collaboration Space to Accommodate Individual Entrepreneurs and Additional Life Science Start-Ups
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... ATLANTA , May 1, 2015 At ... May 2-6 in Washington D.C. , ... a solution that enables clinicians to leverage the enormous ... Knife radiosurgery treatments conducted each year – to advance ... "Gamma Knife Registry is a cloud-based solution that allows ...
(Date:5/1/2015)... 2015 Braeburn Pharmaceuticals announced today ... focus beyond addiction and pain to include ... has acquired an implantable, six-month formulation of ... treatment of schizophrenia from Endo Pharmaceuticals. With ... to other potential applications of the implant ...
(Date:5/1/2015)... , May 1, 2015  Legendary actor and ... in a new PBAFacts campaign designed to educate and ... learn more about Pseudobulbar Affect (PBA) and to speak ... that an actor has the ability to cry and ... lack of control experienced by people living with PBA ...
Breaking Medicine Technology:Elekta to showcase Leksell Gamma Knife Registry at AANS Annual Meeting 2Elekta to showcase Leksell Gamma Knife Registry at AANS Annual Meeting 3Braeburn Pharmaceuticals expands pipeline to include two schizophrenia treatments 2Braeburn Pharmaceuticals expands pipeline to include two schizophrenia treatments 3Braeburn Pharmaceuticals expands pipeline to include two schizophrenia treatments 4Danny Glover Joins PBA Facts Campaign, to Educate and Build Awareness of Pseudobulbar Affect (PBA), a Little Known but Widespread Neurologic Condition 2Danny Glover Joins PBA Facts Campaign, to Educate and Build Awareness of Pseudobulbar Affect (PBA), a Little Known but Widespread Neurologic Condition 3
... Sheets: MDBX ) ( www.thedispensingsolution.com ) announced today ... secure medicine storage and retrieval system. This ... their filled prescriptions from a convenient self-serve system that could ... process is as simple as it is ingenious: When a ...
... WASHINGTON, Nov. 16, 2011 The Personalized Medicine ... its landmark report, The Case for Personalized ... commercially available personalized medicine products from 13 in ... the continued development and adoption of personalized medicine ...
Cached Medicine Technology:MedBox Develops Patent-Pending System for Storage and Retrieval of Prescription Drugs 272 Prominent Personalized Medicine Products Available; A Five-Fold Increase in Five Years 2
(Date:5/1/2015)... 2015 Royal River Natural Foods, a ... on a new study that found two natural nutrients, ... improved physical function as well as standard drug treatment ... the knee. , The report is part of the ... Being® ,” which Royal River Natural Foods publishes for ...
(Date:5/1/2015)... 01, 2015 TROY Healthcare Solutions is ... Regional User Group (RUG) Conference in Atlanta, GA from ... User Group Conference provides a forum for client-to-client presentations, ... all aspects of electronic medical record operations, as well ... applications. , In addition to sponsoring the event, TROY ...
(Date:5/1/2015)... Hope For The Warriors® thanks All American ... Warriors® and military families. All American Ford presented two ... Warriors®, a national nonprofit dedicated to restoring a sense ... for our service members and our military families. , ... and matched small autograph fee from fans and presented ...
(Date:5/1/2015)... Yorba Linda, CA (PRWEB) May 01, 2015 ... of our genetic makeup and the interplay of genes ... Keeping up with developments can be daunting. , LabRoots, ... sciences and clinical diagnostics professionals, will soon host its ... Genomics. , At BioConference Live Genetics and Genomics ...
(Date:5/1/2015)... D.C. (PRWEB) May 01, 2015 Today the ... is expanding its fundraising efforts to help protect the rights ... first new program support country added since Girl Up began ... fundraising campaign aimed at supporting adolescent girls in the Rajasthan ... Girl Up has supported the advancement of adolescent girls in ...
Breaking Medicine News(10 mins):Health News:New Study Finds Nutrients Ease Arthritis Pain, Retailer Reports 2Health News:TROY Healthcare to Exhibit at the Cerner Southeast Regional User Group Conference 2Health News:TROY Healthcare to Exhibit at the Cerner Southeast Regional User Group Conference 3Health News:All American Ford Presents Donation to Nonprofit Hope For The Warriors 2Health News:Recent Advances in Genetics and Genomics: A BioConference Live 2015 Virtual Event 2Health News:Recent Advances in Genetics and Genomics: A BioConference Live 2015 Virtual Event 3Health News:United Nations Foundation’s Girl Up Campaign Announces New Funding Initiative to Support Adolescent Girls in India 2Health News:United Nations Foundation’s Girl Up Campaign Announces New Funding Initiative to Support Adolescent Girls in India 3
... (HealthDay News) -- Cotton swabs offer a cheap, effective ... Daily use of dry cotton swabs to gently ... dramatically reduced surgical site infections, the study revealed. Only ... developed infections, compared with 19 percent of patients in ...
... News) -- The number of U.S. workers aged 16 and ... than half over the past two decades -- from 14 ... 2009, a new study reveals. "Although the prevalence of ... lead exposure are well characterized," researchers from the U.S. Centers ...
... University of Gothenburg, have identified a series of ... carry specific sugar molecules, are found in greater concentrations ... in patients with dementia caused by other diseases. This ... future. , Gran Larson is a professor at the ...
... bacteria are proving effective platforms for delivering medicines and ... building blocks for tiny battery electrodes and computer data ... research over the last two decades, with explanations aimed ... and outside the field, is described in a new ...
... N.C. June 30, 2011 Insomnia is the ... of the adult population in the United States on ... Center is conducting the first ever, randomized, controlled clinical ... treat people with insomnia. Brainwave Optimization is a non-invasive ...
... children who watch adverts for unhealthy food on television are more ... study by researchers in the Institute of Psychology, Health and Society ... six to 13 years old from the North West of England. ... cartoon before being shown it again two weeks later. In ...
Cached Medicine News:Health News:Cotton Swabs Help Prevent Surgical Site Infections: Study 2Health News:On-the-Job Lead Exposures Falling, But Still a Problem: CDC 2Health News:New clues to the cause of Alzheimer's disease 2Health News:Turning agents of disease into tools for health and better living 2Health News:Wake Forest Baptist conducts clinical study for insomnia using new technology 2Health News:TV food advertising increases children's preference for unhealthy foods 2
... Featuring up to ... allows examination in the ... sections plus the option ... for corneal transillumination., ,Filters ...
... to 20 tilting tower ... the vertical, horizontal and ... option to offset the ... ,Filters include Cobalt blue; ...
... outstanding optical system of the Keeler SL-40H, ... fibre optic illumination system with diffuser added ... camera. The result is an excellent digital ... option of capturing stills or video clips ...
With a high lens and filter range this ophthalmoscope is ideal for the Primary Care Specialist...
Medicine Products: